August 22, 2025

FDA Agreement for AXPAXLI Registrational Trial

Ocular Therapeutix secures FDA agreement on NPDR trial design

The Ophthalmologist

August 22, 2025

Osteoporosis and AMD Risk

Study explores the link between osteoporosis and AMD with data taken from NHANES

The Ophthalmologist

August 21, 2025

Michael F. Chiang: Power List Perspectives

Our 2025 Power Lister winners explore the major trends in their field, and the seismic impact AI and machine learning is having on the profession

The Ophthalmologist

August 20, 2025

Why Premium is the New Safe Ground in Refractive Surgery

How to move beyond pricing fear and create higher-tier care patients are eager to choose. By Rod Solar.

The Ophthalmologist

August 20, 2025

One Hour on Phone, Fewer Blinks

Blinking decreases and eye strain increases during one hour of smartphone use, with dynamic screen changes from social media reels creating the highest visual load.

Conexiant

August 19, 2025

Sleep, the Best Medicine?

IOVS study highlights sleep as modifiable risk factor in age-related ocular disease

The Ophthalmologist

August 19, 2025

Presbyopia Correction: Advancements in Corneal-Based Approaches

New corneal-based solutions are reshaping presbyopia care, writes Aanchal Gupta

The Ophthalmologist

August 18, 2025

The Earth: Still Worth Fighting For

What actions can ophthalmology take to promote sustainability and reduce carbon emissions?

The Ophthalmologist

August 18, 2025

How Patients with Chronic Conditions Rate US Health Care

Report highlights strengths and weaknesses in chronic care across five key health care categories.

Conexiant